These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22567517)

  • 1. Management of a Type I Hypersensitivity Reaction to IV Etoposide in a Woman with a Yolk Sac Tumor: A Case Report.
    Starks D; Prinz D; Armstrong A; Means L; Waggoner S; Debernardo R
    Case Rep Obstet Gynecol; 2011; 2011():837160. PubMed ID: 22567517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immediate severe hypersensitivity reaction to etoposide phosphate: Case report and review of the literature.
    Pringle NR; Gilbar PJ; Grewal GD
    J Oncol Pharm Pract; 2022 Jun; 28(4):1019-1023. PubMed ID: 35037804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of standard-dose BEP regimen (bleomycin+etoposide+cisplatin) is essential for treatment of ovarian yolk sac tumour.
    Satoh T; Aoki Y; Kasamatsu T; Ochiai K; Takano M; Watanabe Y; Kikkawa F; Takeshima N; Hatae M; Yokota H; Saito T; Yaegashi N; Kobayashi H; Baba T; Kodama S; Saito T; Sakuragi N; Sumi T; Kamura T; Yoshikawa H
    Eur J Cancer; 2015 Feb; 51(3):340-51. PubMed ID: 25559616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bleomycin-induced pulmonary fibrosis after tumor lysis syndrome in a case of advanced yolk sac tumor treated with bleomycin, etoposide and cisplatin (BEP) chemotherapy.
    Doi M; Okamoto Y; Yamauchi M; Naitou H; Shinozaki K
    Int J Clin Oncol; 2012 Oct; 17(5):528-31. PubMed ID: 22127348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of mixed yolk sac tumor and mature teratoma in the spinal cord: case report.
    Mukasa A; Yanagisawa S; Saito K; Tanaka S; Takai K; Shibahara J; Ikegami M; Nakao Y; Takeshita K; Matsutani M; Saito N
    J Neurosurg Spine; 2017 Mar; 26(3):319-324. PubMed ID: 27911225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are 3 cycles of bleomycin, etoposide and cisplatin or 4 cycles of etoposide and cisplatin equivalent optimal regimens for patients with good risk metastatic germ cell tumors of the testis? The need for a randomized trial.
    Culine S; Theodore C; Terrier-Lacombe MJ; Droz JP
    J Urol; 1997 Mar; 157(3):855-8; discussion 858-9. PubMed ID: 9072585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival and reproductive function of 52 women treated with surgery and bleomycin, etoposide, cisplatin (BEP) chemotherapy for ovarian yolk sac tumor.
    de La Motte Rouge T; Pautier P; Duvillard P; Rey A; Morice P; Haie-Meder C; Kerbrat P; Culine S; Troalen F; Lhommé C
    Ann Oncol; 2008 Aug; 19(8):1435-1441. PubMed ID: 18408223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant Bleomycin, Etoposide, and Cisplatin (BEP) Chemotherapy in the Treatment of Extensively Advanced Yolk Sac Tumors: A Single Center Experience.
    Zhang GY; Zhang R; Wu LY; Li B; Li SM
    Int J Gynecol Cancer; 2018 May; 28(4):713-720. PubMed ID: 29461339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic evaluation of cisplatin, etoposide, and bleomycin chemotherapy regimen in high-risk gestational trophoblastic neoplasia].
    Song SQ; Zhang GN
    Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):571-6. PubMed ID: 23141175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary omental yolk sac tumor.
    Lim SH; Kim YH; Yim GW; Nam EJ; Kim YT; Kim S
    Obstet Gynecol Sci; 2013 Nov; 56(6):412-5. PubMed ID: 24396822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment with etoposide phosphate in patients with previous etoposide hypersensitivity.
    Collier K; Schink C; Young AM; How K; Seckl M; Savage P
    J Oncol Pharm Pract; 2008 Mar; 14(1):51-5. PubMed ID: 18337441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Three cases of resected primary mediastinal yolk sac tumor following six courses of bleomycin, etoposide and cisplatin (BEP) combination chemotherapy].
    Fujita A; Ohbuchi Y; Morikawa T; Takabatake H; Tagaki S; Sekine K
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1981-4. PubMed ID: 8978807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary yolk sac tumor of the gluteus: a case report and literature review.
    Li B; Jiang Q; Zhang S; Zhou Y; Zhang QF; OuYang L
    Onco Targets Ther; 2016; 9():4715-9. PubMed ID: 27536133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case Report: Extragonadal Yolk Sac Tumors Originating From the Endometrium and the Broad Ligament: A Case Series and Literature Review.
    Cheng X; Zhao Q; Xu X; Guo W; Gu H; Zhou R; Chen C; Ma D; Wu Y; Ni J; Chen X
    Front Oncol; 2021; 11():672434. PubMed ID: 34211846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of bleomycin on retroperitoneal histology at post-chemotherapy retroperitoneal lymph node dissection of good risk germ cell tumors.
    Cary KC; Pedrosa JA; Kaimakliotis HZ; Masterson TA; Einhorn LH; Foster RS
    J Urol; 2015 Feb; 193(2):507-12. PubMed ID: 25254937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypersensitivity reactions to etoposide.
    Hoetelmans RM; Schornagel JH; ten Bokkel Huinink WW; Beijnen JH
    Ann Pharmacother; 1996 Apr; 30(4):367-71. PubMed ID: 8729891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safe administration of etoposide phosphate after hypersensitivity reaction to intravenous etoposide.
    Siderov J; Prasad P; De Boer R; Desai J
    Br J Cancer; 2002 Jan; 86(1):12-3. PubMed ID: 11857004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic surgery combining chemotherapy for vaginal yolk-sac tumor: a case report.
    Fang X; Du W; Wang Q; Zhao X
    Eur J Gynaecol Oncol; 2015; 36(3):335-8. PubMed ID: 26189265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial.
    Horwich A; Sleijfer DT; Fosså SD; Kaye SB; Oliver RT; Cullen MH; Mead GM; de Wit R; de Mulder PH; Dearnaley DP; Cook PA; Sylvester RJ; Stenning SP
    J Clin Oncol; 1997 May; 15(5):1844-52. PubMed ID: 9164194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extraovarian pelvic yolk sac tumor: case report and review of published work.
    Pasternack T; Shaco-Levy R; Wiznitzer A; Piura B
    J Obstet Gynaecol Res; 2008 Aug; 34(4 Pt 2):739-44. PubMed ID: 18840194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.